Report from the Western Canadian Gastrointestinal Cancer Consensus Conference Virtual Education Series-Transition from Local to System Therapy and Optimal Sequencing of Systemic Therapy for HCC.
SABR
TACE
hepatocellular cancer
immunotherapy
local therapy
systemic therapy
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
29 10 2021
29 10 2021
Historique:
received:
08
10
2021
accepted:
21
10
2021
entrez:
13
12
2021
pubmed:
14
12
2021
medline:
24
3
2022
Statut:
epublish
Résumé
The Western Canadian Gastrointestinal Cancer Consensus Conference (WC-5) convened virtually on 10 February 2021. The WC-5 is an interactive multidisciplinary conference attended by health care professionals from across Western Canada (British Columbia, Alberta, Saskatchewan, and Manitoba) who are involved in the care of patients with gastrointestinal cancer. Surgical, medical, and radiation oncologists; pathologists; radiologists; and allied health care professionals participated in presentation and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses current issues in the management of hepatocellular cancer (HCC). Recommendations have been made for the transition from local to systemic therapy and the optimal sequencing of systemic regimens in the management of HCC.
Identifiants
pubmed: 34898545
pii: curroncol28060367
doi: 10.3390/curroncol28060367
pmc: PMC8628771
doi:
Types de publication
Congress
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4317-4327Références
Lancet Oncol. 2018 Jul;19(7):940-952
pubmed: 29875066
Clin Oncol (R Coll Radiol). 2020 Jul;32(7):423-432
pubmed: 32093876
Ann Surg. 1999 Jun;229(6):790-9; discussion 799-800
pubmed: 10363892
Gastroenterology. 2017 Jun;152(8):1954-1964
pubmed: 28283421
Hepatology. 2003 Feb;37(2):429-42
pubmed: 12540794
J Surg Oncol. 2016 Jul;114(1):99-105
pubmed: 27103352
Jpn J Clin Oncol. 1997 Oct;27(5):321-4
pubmed: 9390209
J Vasc Interv Radiol. 2010 Aug;21(8 Suppl):S204-13
pubmed: 20656230
JAMA Oncol. 2018 May 1;4(5):661-669
pubmed: 29543938
Gastroenterology. 2011 Feb;140(2):497-507.e2
pubmed: 21044630
J Nucl Med. 2009 Jun;50(6):871-7
pubmed: 19443599
Int J Radiat Biol. 2021;97(2):111-119
pubmed: 33253598
PLoS One. 2020 Mar 4;15(3):e0229696
pubmed: 32130270
N Engl J Med. 2008 Jul 24;359(4):378-90
pubmed: 18650514
Dig Dis. 2017;35(6):602-610
pubmed: 29040999
J Gastrointest Surg. 2012 Oct;16(10):1897-909
pubmed: 22836922
Cardiovasc Intervent Radiol. 2007 Jan-Feb;30(1):6-25
pubmed: 17103105
Clin Oncol (R Coll Radiol). 2019 Jun;31(6):365-373
pubmed: 30792051
Lancet. 2017 Jun 24;389(10088):2492-2502
pubmed: 28434648
PLoS One. 2019 Jan 14;14(1):e0210730
pubmed: 30640924
Cancer. 2010 Mar 1;116(5):1305-14
pubmed: 20066715
Hepatol Res. 2018 May;48(6):442-450
pubmed: 29278654
J Clin Oncol. 2020 Jan 20;38(3):193-202
pubmed: 31790344
N Engl J Med. 2018 Jul 05;379(1):54-63
pubmed: 29972759
Radiother Oncol. 2020 Apr;145:63-70
pubmed: 31923711
Lancet. 2018 Mar 24;391(10126):1163-1173
pubmed: 29433850
Semin Liver Dis. 2010 Feb;30(1):52-60
pubmed: 20175033
Oncotarget. 2016 Nov 1;7(44):72343-72355
pubmed: 27579537
Cancer. 2020 Jan 15;126(2):363-372
pubmed: 31747476
N Engl J Med. 2020 May 14;382(20):1894-1905
pubmed: 32402160
Radiology. 2002 Jul;224(1):47-54
pubmed: 12091661
Lancet. 2017 Jan 7;389(10064):56-66
pubmed: 27932229
Oncology. 2014;87 Suppl 1:32-6
pubmed: 25427731
Hepatology. 2018 Jan;67(1):422-435
pubmed: 28881497